As of January 23, 2025, Ensysce Biosciences (ENSC) has a market cap of $10.805 million USD. According to our data, Ensysce Biosciences is ranked No.8836 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $10.80 M |
1.72%
|
Dec 31, 2024 | $10.62 M |
-48.81%
|
Dec 29, 2023 | $20.75 M |
-88.22%
|
Dec 30, 2022 | $0.18 B |
-99.20%
|
Dec 31, 2021 | $22.08 B |
-62.20%
|
Dec 31, 2020 | $58.42 B |
19.34%
|
Dec 31, 2019 | $48.95 B |
6.11%
|
Dec 31, 2018 | $46.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Trevena
TRVN
|
$1.61 M |
0.000 M
|
USA
|
Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
Collegium Pharmaceutical
COLL
|
$1.05 B |
0.000 M
|
USA
|
Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Heron Therapeutics
HRTX
|
$0.25 B |
0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Market Cap | = | ENSC Stock Price | * | ENSC Shares Outstanding |
= | $8.28 | * | 1.30 M | |
= | $10.80 M |